QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity.

Authors: Kojuri J,Nazarinia MA,Ghahartars M,Mahmoody Y,Rezaian Gr,Liaghat L,
Address: Cardiology Department, Shiraz University of Medical Sciences, Iran. kojurij@yahoo.com
Journal: BMC Cardiovasc Disord.


Publication: 2012 Feb 27;12:11. doi: 10.1186/1471-2261-12-11.

abstract

BACKGROUND:

patients with systemic lupus erythematosus (SLE) have increased cardiovascular morbidity and mortality. Although autopsy studies have documented that the heart is affected in most SLE patients, clinical manifestations occur in less than 10%. QT dispersion is a new parameter that can be used to assess homogeneity of cardiac repolarization and autonomic function. We compared the increase in QT dispersion in SLE patients with high disease activity and mild or moderate disease activity.

METHODS AND RESULTS:

One hundred twenty-four patients with SLE were enrolled in the study. Complete history and physical exam, ECG, echocardiography, exercise test and SLE disease activity index (SLEDAI) were recorded. Twenty patients were excluded on the basis of our exclusion criteria. The patients were divided to two groups based on SLEDAI: 54 in the high-score group (SLEDAI > 10) and 50 in the low-score group (SLEDAI < 10).QT dispersion was significantly higher in high-score group (58.31 ± 18.66 vs. 47.90 ± 17.41 respectively; P < 0.004). QT dispersion was not significantly higher in patients who had received hydroxychloroquine (54.17 ± 19.36 vs. 50.82 ± 15.96, P = 0.45) or corticosteroids (53.58 ± 19.16 vs. 50.40 + 11.59, P = 0.47). There was a statistically significant correlation between abnormal echocardiographic findings (abnormalities of pericardial effusion, pericarditis, pulmonary hypertension and Libman-Sacks endocarditis) and SLEADI (P < 0.004).

CONCLUSIONS:

QT dispersion can be a useful, simple noninvasive method for the early detection of cardiac involvement in SLE patients with active disease. Concerning high chance of cardiac involvement, cardiovascular evaluation for every SLE patient with a SLEDAI higher than 10 may be recommended.

TRIAL REGISTRATION:

Clinicaltrial.gov registration NCT01031797.



Related Articles
QT dispersion increases in patients with systemic lupus erythematosus.
Clin Rheumatol. 2007
QT dispersion increases in patients with systemic lupus erythematosus.
Yavuz B, Atalar E, Karadag O, Tulumen E, Ozer N, Akdogan A, Ertenli I, Kiraz S, Calguneri M, Ozmen F. Clin Rheumatol. 2007 Mar; 26(3):376-9. Epub 2006 Aug 2.
Review Cardiovascular manifestations of systemic lupus erythematosus: current perspective.
Prog Cardiovasc Dis. 1985
Review Cardiovascular manifestations of systemic lupus erythematosus: current perspective.
Ansari A, Larson PH, Bates HD. Prog Cardiovasc Dis. 1985 May-Jun; 27(6):421-34.
[Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies].
G Ital Cardiol. 1993
[Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies].
Lolli C, Foscoli M, Giofrè R, Tarquinii M, Pasquali S, Toschi GP. G Ital Cardiol. 1993 Nov; 23(11):1125-34.
Evaluation of cardiac autonomic functions in patients with systemic lupus erythematosus.
Lupus. 2012
Evaluation of cardiac autonomic functions in patients with systemic lupus erythematosus.
Yorgun H, Canpolat U, Aytemir K, Ateş AH, Kaya EB, Akdoğan A, Sunman H, Gökçay Canpolat A, Çalgüneri M, Kabakçi G, et al. Lupus. 2012 Apr; 21(4):373-9. Epub 2011 Oct 18.
Review Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature.
Medicine (Baltimore). 2004
Review Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature.
Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Medicine (Baltimore). 2004 Nov; 83(6):348-59.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.